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Mitochondria regulate multiple cell processes, including calcium signaling, apoptosis and
cell metabolism. Mitochondria contain their own circular genome encoding selected
subunits of the oxidative phosphorylation complexes. Recent findings reveal that, in
addition to beingmaternally inherited, mitochondria can traverse cell boundaries and thus
be horizontally transferred between cells. Although, the physiological relevance of this
phenomenon is still under debate, mitochondria uptake rescuesmitochondrial respiration
defects in recipient cells and regulates signaling, proliferation or chemotherapy resistance
in vitro and in vivo. In this review, we outline the pathophysiological consequences of
horizontal mitochondrial transfer and offer a perspective on the cellular and molecular
mechanisms mediating their intercellular transmission, including tunneling nanotubes,
extracellular vesicles, cellular fusion, and GAP junctions. The physiological relevance
of mitochondrial transfer and the potential therapeutic application of this exchange for
treating mitochondrial-related diseases are discussed.
Keywords: horizontal genetic transfer, tunneling nanotubes, mitochondrial diseases, extracellular vesicles,
inflammation, DAMPs, exosomes, communication
INTRODUCTION
Mitochondria regulate cellular homeostasis by controlling energy production, calcium signaling,
cell metabolism and apoptosis. According to the endosymbiotic theory, mitochondria are derived
from eubacteria that engaged in a symbiotic relationship with primitive host cells. They have
maintained some of their ancestral bacterial characteristics, such as a double membrane, a
proteome similar to the α-proteobacteria, and the ability to generate the majority of ATP from
cells in the process of aerobic respiration or oxidative phosphorylation (OXPHOS) (Friedman and
Nunnari, 2014).
Mitochondria are endowed with their own circular genome, which is 16.6 kb in length in
mammalian cells. This mitochondrial DNA (mtDNA) encodes 13 subunits that are essential
components of the electron transport chain, and a translational system made of two ribosomal
RNAs and 22 tRNAs, required for the translation of these proteins (Gustafsson et al., 2016).
During evolution, most of the mitochondrial ancestor genes have been progressively transferred
to the nuclear genome, or lost; while mitochondria have acquired new components and functions
from the host cell (Keeling and Palmer, 2008). A typical mammalian cell contains thousands of
copies of the mitochondrial genome, which are organized in mtDNA-protein complexes known as
nucleoids (Kukat et al., 2015). The mitochondrial genome copies of a given cell can be identical
(homoplasmy), or contain more variants (heteroplasmy). Although it was generally assumed that
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healthy individuals exhibit homoplasmy for a single mtDNA
genotype, next-generation sequencing has revealed the presence
of low-level heteroplasmy in most tissues from healthy
individuals (He et al., 2010; Payne et al., 2013). The source
of this heteroplasmy is likely to be maternally inherited, as
some of the low-frequency alleles found in an individual can
also be found in the mother. They may also stem from
somatic mutations that occur during tissue development and
aging. In inherited mitochondrial DNA diseases, individuals
are typically heteroplasmic and harbor both wild-type and
pathogenic mtDNA molecules. Although, cells can tolerate a
heavy load of pathogenic mutations, these will lead to disease
when the mutation load surpasses a tolerable threshold, causing
multisystemic diseases that specially affect organs with high
energy requirements such as the brain, muscle, and heart.
Additionally, many somatic mutations in mtDNA are related to
a number of other pathologies such as cancer, cardiovascular
diseases and neurodegenerative disorders, as well as the normal
aging process (Wallace, 2013).
In mammals, mitochondria are transmitted to subsequent
generations exclusively through the maternal lineage.
Uniparental germline inheritance reduces the benefits of
recombination arising from sexual reproduction, also facilitating
the appearance of maternally inherited disorders when a
significant amount of mtDNA mutations are transmitted to the
offspring. To counteract this, the mtDNA population undergoes
a restricted process of purifying selection during oogenesis,
allowing only a small population of mtDNA molecules to be
amplified and transmitted. Moreover, selective replication and
degradation can expand a subpopulation of mtDNA molecules
at the expense of others, leading to the rapid segregation
of mtDNA variants within a few generations (Stewart and
Larsson, 2014). During somatic cell proliferation, symmetric cell
division implies that mitochondria and mtDNA are distributed
between both daughter cells. Segregation of mitochondria
and mtDNA involves mitochondrial fission, facilitated by the
interaction of mitochondria with cytoskeletal and endoplasmic
reticulum elements (Friedman et al., 2011; Lewis et al., 2016).
Mitochondrial partitioning during symmetric division can
be envisioned as a stochastic process in which mitochondrial
subunits are distributed randomly between daughter cells.
Conversely, recent findings suggest that asymmetric cell
division differentially segregates young and old mitochondria,
revealing the existence of active mechanisms that guide
mitochondria partitioning between daughter cells (Katajisto
et al., 2015).
Several mechanisms maintain the integrity of mitochondria
and mitochondrial genome in post-mitotic cells. Constant
cycles of fusion and fission promote the intermixing and the
homogenization of mitochondrial proteins, lipids and DNA
between discrete organelles within the same cell (Mishra and
Chan, 2014). Consistent with this, cells lacking proteins involved
in mitochondrial dynamics, e.g., mitofusins, show a striking
heterogeneity among mitochondria in terms of protein and
mtDNA nucleoid content, and membrane potential (Chen et al.,
2010). This causes defects in the respiratory chain function and
promotes the accumulation of mtDNA mutations. The selective
elimination of mitochondria through mitophagy eliminates
deleterious mitochondrial mutations in heteroplasmic cells,
restoring ATP levels and mitochondrial functions (Suen et al.,
2010; Dai et al., 2014; Valenci et al., 2015). However, increased
mitochondrial biogenesis in heteroplasmic cells replenishes the
amount of deleterious mtDNA (Gitschlag et al., 2016; Lin et al.,
2016). Therefore, specific mechanisms regulate the stability and
transmission of mitochondria and their genome during germline
transmission and somatic cell proliferation. This is enabled by
purifying selection and selective replication or degradation of
mtDNA. In non-dividing cells, the dynamics of mitochondrial
networks and their selective degradation or biogenesis maintains
a healthy mitochondria repertoire.
Mitochondria have been recently shown to be horizontally
transferred between mammalian cells, challenging current
concepts of mitochondria and mtDNA segregation and
inheritance. This transfer promotes the incorporation of
mitochondria into the endogenous mitochondrial network
of recipient cells, contributing to changes in the bioenergetic
profile and in other functional properties of recipient cells,
not only in vitro but also in vivo. Moreover, intercellular
transfer of mitochondria involves the horizontal transfer
of mitochondrial genes, which has important implications
in the physiopathology of mitochondrial dysfunction. The
intercellular transfer of mitochondria or their components,
may also result in the initiation of stem cell differentiation,
reprogramming of differentiated cells, or activation of
inflammatory signaling pathways. Diverse structures mediate
intercellular mitochondrial transfer. These include tunneling
nanotubes (TNTs), microvesicles, mitochondrial ejection or
cytoplasmic fusion, among others. Future research in this field
is likely to open new avenues for the treatment of mitochondrial
related disorders, e.g., transfer of healthy, or genetically
corrected, mitochondria.
In this review, we discuss the relevance of mitochondrial
transfer in physiological processes. Starting from an integrated
view of the molecular mechanisms mediating intercellular
mitochondrial transmission, we delve into the pathophysiological
consequences of horizontal mitochondrial transfer. Finally, we
discuss how intercellular mitochondrial transfer can be exploited




The existence of nanotubular structures mediating the transfer
of many cellular constituents (Rustom et al., 2004) has
demonstrated the widespread ability of mammalian cells to
donate or receive organelles from other cells (Gerdes et al.,
2007; Davis and Sowinski, 2008). Such transfer involves many
different cell types in vitro and in vivo, including lymphocytes,
neurons or cardiomyocytes. Organelle exchange represents
a special form of intercellular communication that allows
unidirectional or bidirectional transfer, not only of signals, small
molecules or ions, but also of defined intracellular structures
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such as mitochondria, lysosomes, endosomal vesicles and plasma
membrane components (Rogers and Bhattacharya, 2013).
The first evidence of functional mitochondrial transfer
involved healthy mitochondria from human stem cells rescuing
mitochondrial respiration in mitochondria-depleted recipient
cells (Spees et al., 2006). Cells devoid of intrinsic mitochondrial
function by mtDNA depletion through long-term ethidium
bromide treatment, do not survive in standard media. However,
when these cells were co-cultured with mesenchymal stem cells
(MSCs) or fibroblasts that donated functional mitochondria, they
acquired mitochondria and re-established aerobic respiration.
The careful examination of mitochondrial and nuclear DNA
polymorphisms in the rescued clones excluded cell fusion as
the main mechanism of mitochondrial transfer, also confirming
the stem cell origin of the transferred mtDNA (Spees et al.,
2006). Transfer did not occur through the passive uptake
of mitochondrial fragments or isolated organelles, but rather
involved active processes such as the formation of TNTs and/or
the vesicular transfer of mtDNA or mitochondrial fragments.
Other groups have demonstrated that the horizontal cell-to-
cell transfer of mitochondria and mitochondrial genome can
occur among many other mammalian cells in vitro and in
vivo (Berridge et al., 2016). Mitochondrial transfer supports
the exogenous replacement of damaged mitochondria, thereby
rescuingmitochondrial defects (Hayakawa et al., 2016; Patananan
et al., 2016). Most studies used stem cells as mitochondrial
donors, but some others also used immortalized cells or primary
cells from the same or different species (Berridge et al.,
2016). Although, there are some concerns regarding whether
intercellular mitochondrial transfer is a physiologically relevant
process or it is only observed in cell culture conditions, recent
evidence strongly supports that mitochondrial transfer does
occur in vivo and may be involved in diverse pathophysiological
situations, such as tissue injury and cancer progression (Islam
et al., 2012; Ahmad et al., 2014; Tan et al., 2015; Hayakawa et al.,
2016; Moschoi et al., 2016).
Intercellular mitochondrial transfer rescues injured cells from
mitochondrial dysfunctions related with several models of cell
survival associated to stress responses.MSC improve survival and
restore cell damage by transferring their mitochondria through
TNTs to EC or cardiomyocytes previously subjected to an in vitro
model of ischemia-reperfusion, in which cells are cultured under
glucose-oxygen deprivation and then reoxygenated (Liu et al.,
2014; Han et al., 2016). Similarly, the transfer of mitochondria
from MSC to human umbilical vein endothelial cells (HUVEC)
previously subjected to in vitro ischemia-reperfusion, restores
aerobic respiration in EC independently of cellular trans-
differentiation or the release of paracrine factors. Notably,
aerobic restoration is not reestablished in HUVEC when these
are cultured alone or with MSCs containing dysfunctional
mitochondria promoted by mtDNA depletion (Liu et al., 2014).
Interestingly, phosphatidylserine exposure on injured endothelial
cells acts as a “find-me” signal that triggers the emergence of
tunneling nanotubes and guides them from MSC to injured
HUVECs (Liu et al., 2014). Mitochondrial transfer from MSCs
to lung epithelium also attenuates cigarette smoke-induced lung
damage (Li et al., 2014), while transfer between MSC and innate
immune cells via TNTs and microvesicle secretion enhances the
capacity of alveolar macrophages to engulf invading bacteria
in an E.coli pneumonia model (Jackson et al., 2016). Based on
these results, it has been proposed that cell stress is required
for organelle transfer. Mitochondrial transfer is triggered by
an almost complete absence of mitochondrial function, such as
mtDNA depletion or treatment with mitochondrial inhibitors,
since transfer is not detected to cells harboring pathogenic
mutations that partially affect mitochondrial function (Cho et al.,
2012; Wang and Gerdes, 2015). An intriguing question pertains
to the degree of cellular damage required to initiate intercellular
transfer of functional mitochondria. We also ponder about the
mechanisms by which the healthy cell detects the degree of
metabolic shutdown of the stressed cell and makes a “judgment
call” to restore the functionality of the stressed cell, instead of
permitting apoptosis to remove the damaged cell. This would
be of particular interest in non-replaceable cell lineages such as
adult neurons. Accordingly, the transfer of mitochondria from
astrocytes to neurons has a neuroprotective effect after stroke
(Hayakawa et al., 2016).
Mitochondrial transfer seems to be involved in stem cell-
triggered repair of damaged cells (Plotnikov et al., 2008).
Mitochondrial transfer from stem cells to lung epithelial cells
and endothelial cells is an important mechanism by which
MSC exert their protective effects in several animal models
of lung diseases. A seminal study demonstrated that transfer
of intact mitochondria can contribute to tissue repair in vivo
(Islam et al., 2012). In that study, bone marrow-derived stem
cells (BMSCs) infused to the trachea of lipopolysaccharides
(LPS)-treated mice attached to injured alveolar epithelial cells
by a mechanism involving connexins (Figure 1). Connexin
oligomerization forms channels or GAP junctions that connect
two cells, allowing the transfer of only small metabolites,
ions or small RNAs. Connexins, and specifically connexin-43,
regulate intercellular mitochondrial transfer by promoting the
attachment of BMSCs to LPS-injured alveolar epithelial cells,
leading to the formation of nanotubes and microvesicles that
mediate mitochondrial transfer. Mitochondria acquisition by
the alveolar cells triggered the restoration of ATP levels and
increased the secretion of pulmonary surfactant. Silencing of
RISP, a subunit of the mitochondrial complex III, in BMSCs
reduced their capacity to restore ATP levels in recipient alveolar
epithelial cells, avoiding protection from LPS-injury (Islam
et al., 2012). These results implicated mitochondrial transfer
as a driver of the in vivo benefits of mesenchymal stem cell
therapy in models of acute lung injury and other inflammatory
diseases, enhancing cellular bioenergetics and improving organ
function. A follow-up study in mice provided a molecular
mechanism to potentially increase the therapeutic efficiency
of MSC by modulating the extent of mitochondrial transfer
(Ahmad et al., 2014). This study described that the levels
of Miro1, a protein connecting mitochondria to cytoskeletal
motor proteins, regulate the efficiency of intercellular movement
of mitochondria. Hence, overexpression of Miro1 in MSC
increased mitochondrial transfer from stem cells into stressed
epithelial cells via intercellular TNTs, attenuating epithelial cell
apoptosis and reducing inflammatory cell infiltration, collagen
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FIGURE 1 | Cellular mechanisms of intercellular mitochondrial transfer. (A) Tunneling nanotubes (TNT) are long ultrathin structures with diameters ranging from
50 to 200 nm and a length that allow organelle transfer between two spatially separated cells. TNTs contain cytoskeletal elements such as actin and microtubules
depending on the cell type. Myosin is a fundamental protein for the organelle transfer, a process where high rates of ATP consumption are needed. Rho GTPases play
an important role in organelle transfer through TNT. Miro1 and microtubules have been involved in the transfer of mitochondria upon injury (Ahmad et al., 2014). (B)
Cell fusion is a process, in which two independent cells fuse their membranes and share organelles and cytosolic compounds, however nuclei remain intact. Cell
fusion can be transitory and therefore lose their integrity transiently or complete, where cells will share cytoplasm continuously, for example in muscle cells. It has been
shown that after myocardial infarct stem cell therapy can lead to a better recovery and it is proved that partial or total fusion events can happen between
cardiomyocytes and stem cells (Oh et al., 2003). By this mechanism mitochondrial respiration can be restored and this could be an indicative marker for cardiac
regeneration after infarct. (C) GAP junctions. LPS treatment increases connexin 43 expression in alveolar cells. Connexins facilitate the attachment of BMSC to the
alveolar epithelial cells, and produce vesicles and nanotubes to share mitochondria with the damaged cells protecting against acute lung injury (Islam et al., 2012).
deposition and mucus hypersecretion in the lungs. Overall,
Miro1 overexpression improves the therapeutic efficiency of
mitochondrial transfer across multiple models of asthma in vivo
and in vitro (Ahmad et al., 2014).
Cancer cells opportunistically acquire mitochondria to
optimize or repair their metabolic machinery. In this regard,
horizontal transfer of mtDNA from host cells to tumor cells
with compromised respiratory function has been described (Tan
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et al., 2015). Tumor cells devoid of mtDNA, a model of extreme
mtDNA damage, acquire mtDNA from surrounding donor
healthy cells, repairing the transcriptional and translational
activity of mtDNA-encoded genes and triggering a substantial
recovery of mitochondrial respiration, as well as tumor initiation
efficacy and metastasis capacity. A major source of healthy
mitochondria in these contexts are stromal cells, which can
modulate the phenotype of the tumor by direct mitochondria
transfer. Cancer cells and stromal cells communicate through
TNTs, and mitochondrial transfer via TNTs from endothelial to
cancer cells enhances their chemoresistance to doxorubicin in
vitro (Pasquier et al., 2013). In addition, mitochondrial transfer
from bone marrow mesenchymal cells to acute myelogenous
leukemia cells in vivo confers chemoresistance and survival
advantage (Moschoi et al., 2016). These findings highlight the
requirement of mitochondrial respiration for tumorigenesis and
metastasis, and support mitochondrial transfer as a mechanism
for the efficient metabolic adaptation of tumor cells to hostile
microenvironments (Tan et al., 2015).
Mitochondrial Transfer beyond Cell Rescue
Intercellular organelle transfer participates in cell differentiation
and/or de-differentiation (Plotnikov et al., 2008, 2010).
Human adipose-derived or bone marrow-derived stem cells
can reprogram differentiated mouse cardiomyocytes into a
progenitor-like state. This process involves partial cell fusion
and mitochondrial transfer. Deprivation of mtDNA in stem
cells dramatically decreased the efficiency of the reprogramming
process. Although, mtDNA depletion may affect cell stemness
and the ability to donate mitochondria, these results suggest that
mitochondrial transfer from stem cells to adult cardiomyocytes
helps their conversion to the progenitor state through metabolic
reprogramming (Acquistapace et al., 2011). Stem cell interaction
with other cell types does not necessarily result in actual
differentiation, but it may rather initiate a proliferative response,
as observed during mitochondrial transfer from vascular smooth
muscle cells to MSCs (Vallabhaneni et al., 2012).
The release of mitochondria or mitochondrial components
into the extracellular space has important immune consequences.
After an episode of acute injury, release of mitochondrial
components into the extracellular medium and bloodstream
may trigger potent pro-inflammatory responses. In fact,
mitochondrial components can be recognized by cells of the
immune system as damage-associated molecular patterns
(DAMPs) (Zhang et al., 2010; Galluzzi et al., 2012; West et al.,
2015). Different mitochondrial proteins such as TFAM, together
with other mitochondrial DAMPs like N-formyl peptides,
mtDNA, cardiolipin or extracellular ATP, robustly activate the
inflammatory response (Weinberg et al., 2015).
Mitochondrial DNA induces inflammation when found
beyond mitochondrial membrane boundaries (Zhang et al.,
2010). Mitochondrial DNA injected directly into mice joints
causes inflammation and arthritis (Collins et al., 2004).Moreover,
mitochondrial DNA that escapes autophagy leads to Toll-like
receptor (TLR) 9-mediated inflammatory responses in a cell-
autonomous manner (Oka et al., 2012). When abnormally
found in the cytosol, mtDNA triggers NRLP3-inflammasome
activation and STING-dependent antiviral signaling (Shimada
et al., 2012; West et al., 2015), which ultimately leads to cell
death. Neutrophils release to the extracellular environment
oxidized mitochondrial nucleoids that activate the interferon
response in pathological situations such as human systemic
lupus erythematosus (Caielli et al., 2016), whereas activated
platelets release into the bloodstream entire mitochondria
or mitochondria encapsulated in microparticles to boost the
inflammatory response (Boudreau et al., 2014). Interestingly,
mtDNA released by eosinophils or basophils contribute to
inflammatory responses creating DNA net traps to fight against
invading pathogens (Yousefi et al., 2008; Morshed et al., 2014).
Mitochondria-dependent activation of the inflammatory
response has important consequences to understand intercellular
mitochondrial transfer. In this regard, innate immune cells
target cells containing allogenic mtDNA (Ishikawa et al.,
2010). Such recognition mechanism, displayed by natural
killer cells and dendritic cells, is not yet understood, but it
is likely to control the extent of intercellular mitochondrial
transfer in pathophysiological conditions. As a consequence,
careful modulation of immune surveillance mechanisms
in recipient cells could be a potential strategy to boost
exogenous mitochondrial donation for therapeutic purposes.
Consistent with this view, MSC secrete microvesicles containing
depolarized mitochondria that are engulfed by macrophages
in the stem cell niche (Phinney et al., 2015). Together with
microvesicles, MSC secrete exosomes that inhibit TLR signaling
and macrophage activation, thereby promoting specific tolerance
to the transferred mitochondria. Also, mitochondrial transfer by
MSCs may enhance their own survival by unloading partially
depolarized mitochondria into more professional phagocytic
cells such as macrophages (Phinney et al., 2015).
A similar process of transcellular degradation of transferred
mitochondria (“transmitophagy”) has been observed in neurons
at the optic nerve head (ONH). Axonal protrusions and evulsions
within the ONH contain mitochondria that are shed from
neurons and degraded by the lysosomes of neighboring astrocytes
(glial cells) (Davis et al., 2014). This process accounts for the
majority of mitochondrial turnover, rather thanmitophagy in the
ganglion cell soma. The most likely reason for this mechanism is
that it is energetically taxing to transport axonal mitochondria
back to the soma for degradation. The system thus takes
advantage of the presence of a subset of astrocytes with extreme
phagocytic activity on the ONH (Davis and Marsh-Armstrong,
2014). In agreement, astrocytes can phagocytose whole synapses
(Chung et al., 2013). A similar autophagy-assisted phagocytosis
is also involved in the turnover of photoreceptor outer segments
by retinal pigment epithelial cells (Kim et al., 2013). Although,
transmitophagy is a relatively novel process in the nervous
system, similar transcellular degradation of mitochondria occurs
in gametes upon fertilization, in which sperm mitochondria are
actively degraded by oocytes by the same molecular machinery
used in autophagy (Al Rawi et al., 2011; Sato and Sato, 2011).
Horizontal Gene Transfer
Although widely observed in prokaryotes, horizontal gene
transfer (HGT) is in general a rare phenomenon in metazoans.
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However, HGT in eukaryotes might be less rare than previously
anticipated (Crisp et al., 2015), and it has likely contributed
to biochemical diversification during animal evolution. The
horizontal transfer of genetic material between species of
Saccharomyces has been postulated during the evolution of
modern yeast species (Marinoni et al., 1999). Likewise, asexual
bdelloid rotifers have experienced extensive HGT from non-
metazoan genes (Gladyshev et al., 2008), which might have
compensated the lack of genetic heterogeneity due to the absence
of sexual recombination (Eyres et al., 2015). One interesting
example is the horizontal transfer of entire genomes via
mitochondrial fusion in the angiosperm Amborella. Specifically,
Amborella mtDNA includes a diverse collection of foreign
sequences corresponding to about six genome equivalents of
mtDNA acquired from mosses, angiosperms and green algae
(Rice et al., 2013).
One of the first evidences of in vivo horizontal mitochondrial
gene transfer was found in a transmissible canine venereal
tumor (CTVT), which is a highly adapted form of cancer
that is transmitted as an allograft during mating of feral dogs.
Phylogenetic evidence supports that CTVT cells periodically
acquire mitochondria from their hosts to support long-term
survival. Gene transfer events might rescue CTVTmitochondrial
function, allowing the tumor to overcome the high mutation rate
that would promote the accumulation of deleterious mutations
in their own mitochondria (Rebbeck et al., 2011).
The intercellular exchange of mtDNA for the maintenance of
heteroplasmy in cells has been recently proposed (Jayaprakash
et al., 2015). Heteroplasmy is maintained in individual daughter
cells over multiple cell divisions, which suggests the existence
of active mechanisms that counteract mtDNA drift toward
homoplasmy. Using a novel method to enzymatically purify
mtDNA, the authors demonstrate the intercellular transfer of
mtDNA between cell lines with distinct mtDNA haplotypes in
co-culture experiments (Jayaprakash et al., 2015), raising the
intriguing possibility that horizontal mtDNA exchange may




The molecular and signaling mechanisms by which cells
containing dysfunctional mitochondria acquire mitochondria
from other cells, and how this process is regulated remain
unclear. Cells likely possess mechanisms to trigger organelle
exchange in response to injury signals emanating from the
recipient cell. However, the molecular cues that initiate such
crosstalk are still unidentified. Tunneling nanotubes are seen
so far as the main cellular structure that mediates intercellular
mitochondrial transfer. Other mechanisms have been proposed,
including membrane microvesicles, cell fusion or mitochondrial
ejection. Transfer through these diverse structures may result
in different functional outcomes for the recipient cells, i.e.,
functional mitochondrial acquisition, immune activation or
transmitophagy. Thus, a clear understanding on the mechanisms
mediating mitochondrial transmission will shed light on how
mitochondrial transfer is regulated and can be exploited for
therapeutic purposes.
Tunneling Nanotubes
Tunneling nanotubes (TNTs) form between different cell types in
vitro and in vivo (Figure 1). Tunneling nanotubes facilitate the
selective exchange of organelle or membrane vesicles and small
soluble cytoplasmic andmembranemolecules. The establishment
of a nanotube begins with the formation of a filopodium-like
membrane protrusion that retracts after reaching the receptor
cell, leaving an ultrafine structure that is separated from the
substrate. TNTs appear to be essential for effective mitochondrial
transfer, since impairing TNT formation with chemical inhibitors
or mechanical stress reduces mitochondrial exchange, whereas
inhibition of phagocytosis, endocytosis or exocytosis have little
or no effect (Bukoreshtliev et al., 2009). Transfer of mitochondria
through TNTs is usually unidirectional, from the cell that
initiated the formation of TNT to the receptor cell (Rustom et al.,
2004; Bukoreshtliev et al., 2009). However, bidirectional transfer
has also been reported (He et al., 2011).
Certain types of stress agents increase TNT formation and
mitochondrial transfer. Doxorubicin treatment increases
mitochondrial transfer from endothelial progenitors to
mature endothelial cells challenged with doxorubicin (Yasuda
et al., 2010), while ethidium bromide treatment enhances
mitochondrial transfer from MSC to osteosarcoma-treated cells
(Cho et al., 2012). Similarly, multipotent mesenchymal stem
cells transfer mitochondria to lung epithelium cells treated
with cigarette smoke (Li et al., 2014). In vivo, acute lung injury
promoted either by rotenone or TNF-treatment is required for
the transfer of mitochondria from stem cells to lung epithelial
cells (Ahmad et al., 2014). In general, mitochondrial damage is
themain trigger of TNT-basedmitochondrial transfer (Figure 1).
Other conditions that favor TNT formation are serum
starvation and hydrogen peroxide. These conditions activate
p53 and nanotube formation in hippocampal astrocytes and
neurons (Wang et al., 2011). Similarly, hyperglycemic or
acidified medium, as well as cytokines that stimulate epithelial-
to-mesenchymal transition, increase mitochondrial transfer
through tunneling nanotube formation (Lou et al., 2012).
Therefore, stress can induce TNT formation, but further research
is required to understand how TNT-mediated mitochondrial
transfer is regulated. Notably, the protein S100A4 and its receptor
guide the direction of nanotube growth (Sun et al., 2012). In
stressed cells, p53 activates caspase-3 to cleave S100A4, creating
a gradient in which the TNT initiating cell has the lower levels of
the protein (Sun et al., 2012).
Extracellular Vesicles
Almost every cell type secretes a heterogeneous population of
vesicles to the extracellular medium. This group of vesicles,
ranging from 40 to 1000 nm, is referred to as extracellular vesicles
(EVs). EVs can be divided into microvesicles, exosomes and
apoptotic bodies, depending on their origin, size and molecular
composition (Figure 2). EVs are vehicles of intercellular
communication in a number physiological and pathological
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FIGURE 2 | Loading of mitochondrial components in Extracellular
Vesicles. Exosomes are small vesicles from 50 to 150 nm with an endocytic
origin. The inward budding of late endosomes or multivesicular bodies (MVB)
forms intraluminal vesicles that are released into the extracellular environment
as exosomes through fusion of the MVB with the plasma membrane.
Microvesicles, also called ectosomes, shed directly from plasma membrane
and are very heterogeneous in size and composition. Apoptotic bodies are
larger than 1µm and are released by apoptotic cells that shed parts of their
cytoplasm and organelles surrounded by plasma membrane (Mittelbrunn and
Sánchez-Madrid, 2012). Extracellular vesicles can contain mitochondrial
fragments which include mitochondrial proteins and mtDNA (depicted in
yellow and orange). Bigger particles can be loaded with full functional
mitochondria (Phinney et al., 2015).
processes (Mittelbrunn and Sánchez-Madrid, 2012), and can be
used as biomarkers of health and disease (Pitt et al., 2016).
Mitochondrial components have been detected in EVs,
although the mechanisms by which mitochondrial proteins
and mtDNA are loaded in the diverse EVs are still unknown.
Exosomes, with a size ranging 40–150 nm, contain genetic
material, mostly small RNAs (Villarroya-Beltri et al., 2014),
but genomic and mitochondrial DNA have also been detected
(Guescini et al., 2010a,b; Kahlert et al., 2014; Thakur et al.,
2014). Larger EVs can contain entire mitochondrial particles and
mtDNA, as observed in mesenchymal stem cells and astrocytes
(Phinney et al., 2015; Hayakawa et al., 2016). These cells produce
EVs with regenerative potential in several tissues under damaging
conditions (Khan et al., 2015; Nakamura et al., 2015; Ong and
Wu, 2015). Whether mitochondrial material contained in these
vesicles participates in the regenerative potential of stem cells is
yet to be shown.
EVs participate in intercellular mitochondrial transfer (Spees
et al., 2006; Islam et al., 2012; Jayaprakash et al., 2015).
Horizontal transfer of mitochondria occurs through the transfer
of either mitochondria-derived vesicles or intact mitochondria.
To date, the mechanisms of intercellular transfer of free mtDNA
across both mitochondrial inner and outer membranes and the
plasma membrane remain elusive. Also, the transfer of whole
mitochondrial particles is the most likely event mediating rescue
of mitochondrial function through EVs during intercellular
mitochondrial transfer, in which some cells would acquire a few
mitochondria and replicate their mtDNA.
Cell Fusion
Cell fusion is a process in which two independent cells fuse
their membranes and share organelles and cytosolic compounds,
while their nuclei remain intact. Permanent cell fusion result in
cells that share the cytoplasm and possess unique karyotypes,
while partial cell fusion allows transient, but direct, intercellular
communication and exchange of multiple protein complexes and
even subcellular organelles, including mitochondria. Fusion is
a rare event in developed eukaryotic organisms, and a strict
regulation of fusogen proteins and their receptors expression
ensures that it only occurs under specific conditions (Aguilar
et al., 2013).
Adult and embryonic stem cells have been reported to fuse
with cardiomyocytes, hepatocytes and neurons, which might
contribute to the differentiation, plasticity, or maintenance
of these cell types (Alvarez-Dolado et al., 2003). Injury and
inflammation may drive cell fusion in target organs. Cells from
the myeloid and lymphoid lineage can fuse in low rates with
different tissues in response to injury or inflammation (Nygren
et al., 2008). Cell fusion improved regeneration in rodent livers
that received bonemarrow transplants (Vassilopoulos et al., 2003;
Wang et al., 2003). Myocardial infarction also triggers fusion
events between cardiomyocytes and bone marrow transplanted
cells (Oh et al., 2003; Figure 1). Similarly, human MSC may
fuse to small airway epithelial cells upon insult ex vivo (Spees
et al., 2003). However, to which extent mitochondrial transfer in
these scenarios participates in the potential of stem cell fusion is
unknown.
Cell fusion can modify the potential of the cells involved,
having important implications in regeneration and cancer
(Aguilar et al., 2013). A major concern is whether fusion is
physiologically relevant, since most studies used pluripotent or
multipotent stem cells as at least one of the fusion partners. It is
difficult to evaluate its actual impact in tissues, since cytokinesis
may occur after fusion events, leaving new synkaryons that could
be hardly distinguished from the rest of the cells in the tissue. This
is the underlying reason why in vivo reports of adult cell fusion
are scarce, apart from those cells that form heterokaryons as part
of their functional cycle, e.g., muscle, placenta or macrophages.
Other Cellular Mechanisms
Mitochondrial extrusion is another possible mechanism for
mitochondrial transfer. It allows the release of mitochondria or
mitochondrial components from cells under specific conditions.
During tumor necrosis factor α-induced cell death, cytoplasmic
vacuoles engulf mitochondria, which subsequently fuse with
the plasma membrane, releasing free mitochondria to the
extracellular medium (Nakajima et al., 2008). Likewise, LPS
stimulation promotes the fusion of autophagolysosomes with the
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 September 2016 | Volume 4 | Article 107
Torralba et al. Intercellular Mitochondrial Transfer
plasma membrane and the release of mitochondrial components
that activate the inflammatory response (Unuma et al., 2015).
Neutrophils can extrude mitochondrial components, specifically
oxidized mitochondrial nucleoids, which boost type I interferon
secretion and can lead to the development of lupus (Caielli
et al., 2016). Under high rates of reactive oxygen species (ROS)
HeLa cells can extrude fragments of mitochondria (Lyamzaev
et al., 2008). Basophils release mtDNA in ROS dependent
manner to create extracellular DNA traps to fight bacteria
(Morshed et al., 2014). Likewise, eosinophils rapidly release
mtDNA in the extracellular space to bind and kill infectious
bacteria (Yousefi et al., 2008). Mitochondrial extrusion not only
occurs in vitro, but also in vivo. For example, platelets extrude
functional mitochondria both encapsulated in microparticles
and as free organelles. This way, they enhance inflammatory
responses (Boudreau et al., 2014). In addition, hepatocytes of
mice treated with anti-Fas antibody extruded mitochondria,
which were detected in the perisinusoidal space and in serum
(Nakajima et al., 2008).
FUTURE PERSPECTIVES AND
THERAPEUTIC OPPORTUNITIES
Horizontal mitochondrial transfer among cells occurs in vitro
and in vivo. However, whether mitochondria move between
cells under physiological conditions, and the precise role of
this transfer remain unknown. Stem cells are likely organelle
donors; thus, adult stem cells, mesenchymal stromal cells,
fibroblasts, and hematopoietic stem cells, emerge as potential
mitochondrial donors. These cells may transfer mitochondria to
surrounding cells in their niche, thus affecting cell differentiation,
proliferation, tissue homeostasis, development and aging. During
the course of an immune response, immune cells show
high capacity to exchange surface receptors and intercellular
material (Rechavi et al., 2009). These cells can also extrude
mitochondrial components under specific conditions (Weinberg
et al., 2015). Regarding the control of immune responses by
those mechanisms, cognate immune cell-cell interactions such as
immune synapses between lymphocytes and antigen-presenting
cells, lymphocyte adhesion and migration across inflamed
tissues or macrophage patrolling, may represent physiological
scenarios in which mitochondrial intercellular exchange could
control signaling, proliferation, bioenergetics or transcellular
degradation of mitochondria. Professional phagocytic cells
involved in inflammation and tissue regeneration may also
acquire exogenous mitochondria (Phinney et al., 2015), as it
has been observed in the optic nerve head (Davis et al., 2014).
Notably, astrocytes transfer mitochondria to neurons supporting
neuronal viability after ischaemic stroke (Hayakawa et al., 2016).
Whether neurons and microglia crosstalk through intercellular
mitochondrial transfer should be further addressed, in order to
determine if defects on this type of communication are involved
in pathogenesis and can represent a therapeutic target.
Unraveling the physiological significance of mitochondrial
transfer requires the development of novel fluorescence and
geneticmitochondrial tracking tools.Many of the studies referred
here use fluorescent dyes to track mitochondrial transfer, but
the possibility of the leakage of these dyes is a limitation for
this methodology. Visualizing intercellular organelle transfer
in real time in the intact living organism remains a major
methodological challenge. The use of available cells and mice
with fluorescent proteins confined to mitochondria will greatly
accelerate the progress in this field (Abe et al., 2011; Pham et al.,
2012). In addition, the use of mtDNA polymorphisms that allow
the distinction of mtDNA from the donor and acceptor cells
after mitochondria acquisition, the development of techniques
to detect mitochondrial transfer (Caicedo et al., 2015) and low
levels of cell heteroplasmy in single cells from tissues, will help
to unequivocally ascertain whethermitochondrial transfer occurs
in the different scenarios. Importantly, the possible exchange of
healthy mitochondria to sustain cells with OXPHOS deficiencies
would prevent the manifestation of some diseases associated with
mitochondrial dysfunction or with the heteroplasmic inheritance
of mutated mtDNA. Hence, additional study is required to
evaluate the real impact of these mechanisms in mitochondrial
diseases.
The number of diseases in which impaired mitochondrial
function is thought to contribute to pathogenesis is currently
increasing. While the main strategy employed in the treatment
of mitochondrial dysfunction involves targeting mitochondrial
genes encoded by the nuclear genome, our current capacity to
supplement, repair, or replace mitochondrial DNA in somatic
cells is very limited (Patananan et al., 2016).
Identification of the signaling pathways and the proteins
controlling the transfer ofmitochondria will improve its potential
therapeutic application. Future therapeutic implications of
this research need to consider strategies to pharmacologically
enhance intercellular organelle transfer when desirable, or block
its occurrence when it is deleterious, such as in the spread
of infection or the maintenance of malignant cells. Given the
considerable therapeutic potential of MSCs and mitochondrial
transfer, future investigation of the mechanisms underlying
the regulation of oxidative metabolism and dynamics of
mitochondria in MSCs may ultimately facilitate the development
of effective stem cell therapies for treatment of mitochondrial
diseases. Elucidation of the mechanisms of mitochondrial
transfer will help us create a potential cell therapy-based
mitochondrial restoration or mitochondrial gene therapy for
human diseases caused by mitochondrial dysfunction.
Another major concern pertains the required transfer dose.
It might not be necessary to fully replace the mitochondria
repertoire in the recipient cell to restore mitochondrial
dysfunction. It is likely that the transfer of a low number of copies
of a functional mtDNA could restore the normal copy number
and therefore the mitochondrial function. Hence, tumors formed
from cells with low copy number of mtDNA are able to recover
them after injection into immunoincompetent mice (Dickinson
et al., 2013). This would open a new field in which mitochondrial
transfer therapy would be an option to treat injured tissues,
taking into account that using healthy mitochondria from the
same patient could lead to a better performance of the tissues
because of the matching between mitochondrial and nuclear
DNA (Latorre-Pellicer et al., 2016).
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